Literature DB >> 20680293

Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies.

Daniel Portalez1, Gautier Rollin, Pierre Leandri, Benjamin Elman, Patrick Mouly, Frédéric Jonca, Bernard Malavaud.   

Abstract

OBJECTIVES: To compare T2-weighted MRI and functional MRI techniques in guiding repeat prostate biopsies.
METHODS: Sixty-eight patients with a history of negative biopsies, negative digital rectal examination and elevated PSA were imaged before repeat biopsies. Dichotomous criteria were used with visual validation of T2-weighted MRI, dynamic contrast-enhanced MRI and literature-derived cut-offs for 3D-spectroscopy MRI (choline-creatine-to-citrate ratio >0.86) and diffusion-weighted imaging (ADC × 10(3) mm(2)/s < 1.24). For each segment and MRI technique, results were rendered as being suspicious/non-suspicious for malignancy. Sextant biopsies, transition zone biopsies and at least two additional biopsies of suspicious areas were taken.
RESULTS: In the peripheral zones, 105/408 segments and in the transition zones 19/136 segments were suspicious according to at least one MRI technique. A total of 28/68 (41.2%) patients were found to have cancer. Diffusion-weighted imaging exhibited the highest positive predictive value (0.52) compared with T2-weighted MRI (0.29), dynamic contrast-enhanced MRI (0.33) and 3D-spectroscopy MRI (0.25). Logistic regression showed the probability of cancer in a segment increasing 12-fold when T2-weighted and diffusion-weighted imaging MRI were both suspicious (63.4%) compared with both being non-suspicious (5.2%).
CONCLUSION: The proposed system of analysis and reporting could prove clinically relevant in the decision whether to repeat targeted biopsies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20680293     DOI: 10.1007/s00330-010-1868-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  38 in total

1.  Diffusion-weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients.

Authors:  S F Riches; K Hawtin; E M Charles-Edwards; N M de Souza
Journal:  NMR Biomed       Date:  2009-04       Impact factor: 4.044

2.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.

Authors:  D Le Bihan; E Breton; D Lallemand; M L Aubin; J Vignaud; M Laval-Jeantet
Journal:  Radiology       Date:  1988-08       Impact factor: 11.105

3.  Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging.

Authors:  Oguz Akin; Evis Sala; Chaya S Moskowitz; Kentaro Kuroiwa; Nicole M Ishill; Darko Pucar; Peter T Scardino; Hedvig Hricak
Journal:  Radiology       Date:  2006-03-28       Impact factor: 11.105

Review 4.  Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study.

Authors:  B Djavan; M Waldert; A Zlotta; P Dobronski; C Seitz; M Remzi; A Borkowski; C Schulman; M Marberger
Journal:  J Urol       Date:  2001-09       Impact factor: 7.450

5.  Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system.

Authors:  Juyoung A Jung; Fergus V Coakley; Daniel B Vigneron; Mark G Swanson; Aliya Qayyum; Vivian Weinberg; Kirk D Jones; Peter R Carroll; John Kurhanewicz
Journal:  Radiology       Date:  2004-12       Impact factor: 11.105

6.  Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy.

Authors:  Byung Kwan Park; Hyun Moo Lee; Chan Kyo Kim; Han Yong Choi; Jong Wook Park
Journal:  Invest Radiol       Date:  2008-11       Impact factor: 6.016

Review 7.  Imaging prostate cancer: a multidisciplinary perspective.

Authors:  Hedvig Hricak; Peter L Choyke; Steven C Eberhardt; Steven A Leibel; Peter T Scardino
Journal:  Radiology       Date:  2007-04       Impact factor: 11.105

8.  Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy.

Authors:  Alexandre Ben Cheikh; Nicolas Girouin; Marc Colombel; Jean-Marie Maréchal; Albert Gelet; Alvine Bissery; Muriel Rabilloud; Denis Lyonnet; Olivier Rouvière
Journal:  Eur Radiol       Date:  2008-10-17       Impact factor: 5.315

9.  High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio.

Authors:  Kazuhiro Kitajima; Yasushi Kaji; Kagayaki Kuroda; Kazuro Sugimura
Journal:  Magn Reson Med Sci       Date:  2008       Impact factor: 2.471

10.  Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study.

Authors:  Jeffrey C Weinreb; Jeffrey D Blume; Fergus V Coakley; Thomas M Wheeler; Jean B Cormack; Christopher K Sotto; Haesun Cho; Akira Kawashima; Clare M Tempany-Afdhal; Katarzyna J Macura; Mark Rosen; Scott R Gerst; John Kurhanewicz
Journal:  Radiology       Date:  2009-04       Impact factor: 11.105

View more
  19 in total

1.  Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard.

Authors:  L Schimmöller; M Quentin; C Arsov; R S Lanzman; A Hiester; R Rabenalt; G Antoch; P Albers; D Blondin
Journal:  Eur Radiol       Date:  2013-06-12       Impact factor: 5.315

2.  Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla.

Authors:  M C Roethke; T H Kuru; S Schultze; D Tichy; A Kopp-Schneider; M Fenchel; H-P Schlemmer; B A Hadaschik
Journal:  Eur Radiol       Date:  2013-10-03       Impact factor: 5.315

Review 3.  [Diffusion-weighted MRI of the prostate].

Authors:  U G Mueller-Lisse; U L Mueller-Lisse; P Zamecnik; H-P W Schlemmer; M K Scherr
Journal:  Radiologe       Date:  2011-03       Impact factor: 0.635

4.  Diagnostic value of semi-quantitative and quantitative analysis of functional parameters in multiparametric MRI of the prostate.

Authors:  Elke Hauth; Daniela Halbritter; Horst Jaeger; Horst Hohmuth; Meinrad Beer
Journal:  Br J Radiol       Date:  2017-07-27       Impact factor: 3.039

5.  MRI-directed cognitive fusion-guided biopsy of the anterior prostate tumors.

Authors:  Ian G Murphy; Elaine NiMhurchu; Robert G Gibney; Colm J McMahon
Journal:  Diagn Interv Radiol       Date:  2017 Mar-Apr       Impact factor: 2.630

6.  Comparison of T2(*) mapping with diffusion-weighted imaging in the characterization of low-grade vs intermediate-grade and high-grade prostate cancer.

Authors:  Lian-Ming Wu; Zi-Zhou Zhao; Xiao-Xi Chen; Qing Lu; Shi-Teng Suo; Qiang Liu; Jiani Hu; E Mark Haccke; Jian-Rong Xu
Journal:  Br J Radiol       Date:  2016-04-19       Impact factor: 3.039

Review 7.  The emerging role of diffusion-weighted MRI in prostate cancer management.

Authors:  Edward M Lawrence; Vincent J Gnanapragasam; Andrew N Priest; Evis Sala
Journal:  Nat Rev Urol       Date:  2012-01-17       Impact factor: 14.432

8.  Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis.

Authors:  Cher Heng Tan; Wei Wei; Valen Johnson; Vikas Kundra
Journal:  AJR Am J Roentgenol       Date:  2012-10       Impact factor: 3.959

9.  Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI.

Authors:  Kyung Won Doo; Deuk Jae Sung; Beom Jin Park; Min Ju Kim; Sung Bum Cho; Yu Whan Oh; Young Hwii Ko; Kyung Sook Yang
Journal:  Eur Radiol       Date:  2012-04-01       Impact factor: 5.315

10.  [Prostate cancer].

Authors:  T Franiel; N Eckardt; M Waginger; M Horstmann
Journal:  Radiologe       Date:  2014-05       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.